Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in Relapsing Multiple Sclerosis (Randomized, Double-Blind, Placebo-Controlled Phase 3 Study)
2004-000555-42Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Teriflunomide with Placebo (2 arms). Primary endpoint: Annual relapse rate. Started Sep 2004; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-000555-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000555-42.